Amgen cholesterol drug could get EU green light this week
May 19, 2015 at 12:04 PM EDT
LONDON, May 19 (Reuters) - Amgen's new cholesterol drug Repatha could be recommended for approval in Europe as early as this week, putting it ahead in a race with a rival product from Sanofi.